PRQR Earnings
ProQR Therapeutics N.V.
1W: -0.6%
1M: -23.7%
3M: -4.7%
YTD: -17.6%
1Y: -24.1%
3Y: +18.8%
5Y: -79.0%
$1.64
+0.01 (+0.31%)
Weekly Expected Move ±6.4%
$1
$2
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Last Earnings
2026-08-13
EPS
€-0.10 (US$-0.11)
▲ Beat +23.3%
Revenue
€10M ($11M)
▲ Beat +119.3%
Next Earnings
2026-11-05
EPS Estimate
€-0.11 (US$-0.13)
Range: €-0.15 - €-0.08
Revenue Estimate
€4M ($4M)
2 analysts
1 USD = 0.89 EUR
Estimate vs Actual
Earnings Surprise History
8/18
EPS Beats
6/18
Revenue Beats
44%
EPS Beat Rate
33%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | quarter | 2027-12-30 | €-0.15 | €-0.15 | — | €3,363,432 | €3,367,005 |
| 2026-10-02 | annual | 2029-12-31 | €-0.38 | €-0.38 | — | €61,882,967 | €61,953,304 |
| 2026-10-02 | quarter | 2027-06-30 | €-0.13 | €-0.13 | — | €3,726,006 | €3,729,991 |
| 2026-10-02 | annual | 2030-12-31 | €0.02 | €0.02 | — | €164,510,978 | €164,697,963 |
| 2026-10-02 | annual | 2027-12-31 | €-0.49 | €-0.49 | — | €19,577,452 | €19,599,078 |
| 2026-10-02 | quarter | 2027-03-30 | €-0.12 | €-0.12 | — | €3,726,006 | €3,729,991 |
| 2026-10-02 | annual | 2028-12-31 | €-0.48 | €-0.48 | — | €51,974,171 | €52,033,245 |
| 2026-10-02 | annual | 2026-12-31 | €-0.42 | €-0.42 | — | €16,708,355 | €16,743,342 |
| 2026-10-02 | quarter | 2026-12-30 | €-0.11 | €-0.11 | — | €3,604,176 | €3,603,409 |
| 2026-10-02 | quarter | 2027-09-30 | €-0.13 | €-0.13 | — | €3,363,432 | €3,367,005 |
| 2026-10-02 | quarter | 2026-09-30 | €-0.10 | €-0.10 | — | €3,787,213 | €3,789,372 |
| 2026-10-01 | annual | 2026-12-31 | €-0.42 | €-0.42 | — | €16,720,828 | €16,708,355 |
| 2026-10-01 | annual | 2029-12-31 | €-0.38 | €-0.38 | — | €61,929,161 | €61,882,967 |
| 2026-10-01 | annual | 2030-12-31 | €0.02 | €0.02 | — | €164,633,783 | €164,510,978 |
| 2026-10-01 | quarter | 2027-12-30 | €-0.15 | €-0.15 | — | €3,365,943 | €3,363,432 |
Earnings Call Transcripts
No transcripts available.